Neonatal MR1T Cells Show Limited Cytotoxicity and Pathogen Response
Healthy adult participants and expectant mothers from the Portland, USA area provided blood and umbilical cord blood samples in a study published on March 18, 2025, on bioRxiv.
Key Clinical Takeaways:
- Neonatal MR1T cells possess diverse T-cell receptor usage at birth.
- Cord blood cells display lower cytotoxicity compared to adult samples.
- Immune cells fail to mount responses against common childhood pathogens initially.
Researchers Compared Gene Expression in Adult and Cord Blood T Cells
Researchers collected peripheral blood mononuclear cells from adult donors and cord blood mononuclear cells from umbilical cord samples at delivery. According to the study, investigators sorted these samples for MR1/5-OP-RU-tetramer positive MR1-restricted T cells. The team performed single-cell gene expression and single-cell TCR-sequencing utilizing the 10X genomics platform.
The primary objective was comparing gene expression and T-cell receptor usage between adults and cord blood samples. This analysis aimed to clarify how these immune cells develop following birth.
MR1T Cells Expand and Mature in the Periphery After Birth
The findings indicate that while MR1T cells emerge from the thymus with baseline effector functions, they undergo expansion in the periphery and continue maturing after birth. Environmental exposures during life influence this development trajectory.
These dynamics carry implications for harnessing these populations in cellular therapy and vaccination strategies. Data derived from adult participants remain accessible through dbGaP under accession phs003810.v1.p1, while cord blood data are scheduled for release via SRA under identifier PRJNA1420691.
Study Participants Met Specific Age and Health Criteria
Adult subjects ranged from 18 to 65 years of age, reported no known health conditions, took no immunosuppressive drugs, and tested negative for HIV and Mycobacterium tuberculosis infection. Infants were delivered at term with no reported health complications.
Use of the tuberculosis-specific data requires adherence to specific protocols overseen by the NIAID Data Access Committee. The research acknowledges contributions from participants alongside Erin Merrifield of the Department of Pediatrics at Oregon Health Science University and Dr. Marielle Gold.
Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.